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BERRY PREPARATIONS AND EXTRACTS

sole (BHA) (Wang et al., 1997; Rice-Evans et al., 1995; Liu et

al., 2002; Proteggente et al., 2002; Wang et al., 1999).
This application claims the bene?t of priority of US. Pro
visional Patent Application Ser. No. 60/720,892 ?led on Sep.
27, 2005, the disclosure of Which is incorporated in its

In?ammation, or the biological state of being in?amed, is

generally characterized by pain, redness, and sWelling, and
may result from physical causes such as injury, chemical

entirety herein by reference.

causes such as exogenous substances including toxins, or
biological causes such as infection by a virus, a bacteria, a

TECHNICAL FIELD

parasite, or other disease-causing agent. As examples, various
conditions associated With in?ammation of the gastrointesti

The present invention relates to compositions having anti
oxidant and anti-in?ammatory activity, derived from a berry.

nal tract are knoWn, including but not limited to acute or
chronic conditions or diseases such as in?ammatory boWel

In particular, the invention relates to a method for deriving an

disease, gastroesophageal re?ux disease, diarrhea, radiation
induced enteritis, chemotherapy-induced enteritis, Crohn’s
disease, irritable boWel syndrome, diverticulitis, ulcers, coli
tis, viral infection, bacterial infection, and parasitic infection

extract having antioxidant and anti-in?ammatory activity
from a berry, and to formulated compositions derived by the
method for oral and topical administration. Still further, the
invention provides methods and compositions for treatment

5

or infestation. In individuals a?llicted With the above and

similar conditions, affected cells such as dendritic cells,

of in?ammation, oxidative stress, or cancer comprising
administering an effective amount of the composition of the
invention.

monocytes, macrophages, ?broblasts, endothelial cells, and T
20

BACKGROUND OF THE INVENTION

cells release causative agents, including cytokines such as
interleukins (IL), tumor necrosis factor (TNF), interferons
(IFN), and the like Which trigger in?ammation and/or an

in?ammatory response. Cytokines important in in?ammation
Polyphenolics (also knoWn as phenolics) are metabolites
found in plants, fruits, and vegetables. Phenolics have a num
ber of functions including acting as free radical scavengers.

include, but are not limited to, IL-1, IL-6, IL-12, TNF-ot, and
25

Thus, phenolics disrupt many biological processes. The most
notable type of phenolics are ?avonoids Which consist of

IFN-ot. Anti-in?ammatory properties, effects, or activity
refers to reducing in?ammation and promoting healing of
cells and tissues subject to in?ammation and/or in?ammatory
processes.
Anti-cancer property, effect, or activity refers to a property
of a substance, chemical, or material that can sloW the prolif

proanthocyanidins, anthocyanidins, ?avones, ?avonols and
their glycosides (Macheix, 1990). Anthocyanins are respon
sible for the red, purple, and blue colors of many fruits and
vegetables. The term anthocyanin refers to a group of pig
ments found in plants, fruits, and vegetables that can be
classi?ed as both ?avonoid and phenolic. Anthocyanins are
not found in animals, microorganisms, or marine plants. It is

30

thought that anthocyanins function by attracting insects to

35

eration of tumor cells (termed anti-proliferative effect), or kill
tumor cells (termed cytotoxic effect). Recent studies have
shoWn also that berries such as black raspberries possess
cancer-preventing properties at both in-vitro and in-vivo lev
els (Kresty et al., 2001; Castro et al., 2002; Xue et al., 2001;
Huang et al., 2002; Rodrigo et al, in press; US. patent appli
cation Ser. No. 10/951,413). In particular, anthocyanins have

promote pollination but also to protect the plants from dam
age caused by ultraviolet (UV) radiation. Anthocyanins are

been shoWn to demonstrate a Wealth of chemopreventive

glycosides of polyhydroxyl and polymethoxyl derivatives of

properties (Hecht et al., in press; Liu et al., 2002; Katsube et

2-phenylbenZopyrylium or ?avylium salts, and are soluble in
Water. The anthocyanins are electron de?cient, and are there

40

fore are strong scavengers for reactive oxygen species (ROS)

al., 2003; Hu et al., 2003).
HoWever, anthocyanin compounds are inherently unstable
both in vivo and in vitro, and tend to degrade over time,
negating any health or medical bene?ts associated thereWith

such as free radicals. Although there are hundreds of different

anthocyanins found in nature, six anthocyanin compounds

(Rubinskiene et al., 2005; Nielsen et al., 2003; Morais et al.,

predominate including: delphinidin, petunidin, cyanidin, pel

2002). A need in the art therefore exists for methods for

argonidin, peonidin, and malvidin. The daily intake of antho
cyanins in the United States is about 180-215 mg/day, and
constitute the largest intake of phenolic compounds (Hertog,
1 993).
Anthocyanins originally dreW interest due to their role in

45

color degradation in fruits, and their potential use as natural

50

preparing compositions from anthocyanin-containing fruits
such as berries Which provide a stable anthocyanin content.

food colorants. More recently, anthocyanins have received

Still further, there is a need for compositions including such
stable anthocyanin compositions to provide health and medi
cal bene?ts to individuals utiliZing them. In particular, com
positions formulated for oral administration and topical
administration are described herein. HoWever, it Will be
appreciated that other formulations are contemplated and can

attention because of their possible health bene?ts as natural

antioxidant and anti-in?ammatory compounds, and poten
or reverse oxidation or the effects of oxidation, such as for

be derived by the skilled artisan from the teachings herein
using methods knoWn in the art, including injectable formu
lations. Accordingly, the present invention contemplates also
injectable formulations including, but not limited to, solu

example the oxidative process caused by free radicals. A free

tions, suspensions, emulsion, microemulsions, micelles, lipo

tially as anti-cancer compounds. Antioxidant property,
effects, or activity refers to compositions that inhibit, reduce,

55

radical may be any chemical species that includes one or more

somes, nanoparticles, microparticles, implants, depots, and

unpaired electrons, and Without limitations includes chemi
cals such as hydroxyl radical, superoxide radical, nitric oxide,
and nitrogen dioxide. Examples of conditions involving free

polymer conjugates.
60

SUMMARY OF THE INVENTION

radical oxidative damage include, but are not limited to,

The present invention provides methods for deriving stable

aging, disease, stress, ultraviolet radiation, exercise, cancer,
smoking, atherosclerosis, and chronic in?ammation. Studies
shoWed that antioxidant activity of cyanidins Was greater than
that of vitamin E and Trolox, and comparable to that of

butylated hydroxytoluene (BHT) and butylated hydroxyani

compositions from blackberries, and compositions incorpo
65

rating such stable compositions. In one aspect, a method is

provided for preparing a composition having antioxidant and
anti-in?ammatory activity, comprising exposing a berry to a
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solvent composition having a pH of from about 1 to about 3,
and recovering a berry extract having a stable anthocyanin

FIG. 4 shoWs the stability of a speci?c anthocyanin (cya
nidin-3-glucoside) in a blackberry preparation made accord

content. The berry may be a blackberry. In one embodiment,

ing to the present invention as a function of time and storage

the method comprises the steps of physically disrupting a

condition;

quantity of berries, exposing the physically disrupted berries

FIGS. 5A and 5B shoW the stability of anthocyanins in

to the solvent composition, and recovering a berry extract
having a pH of from about 1.0 to about 4.5. The berry extract
so recovered typically comprises at least one stable anthocya

blackberry preparations made according to the present inven

nin in an amount effective to provide antioxidant and anti

capsules containing a berry composition according to the

in?ammatory activity. In another embodiment, the recovered

present invention;

tion as a function of time and temperature;

FIG. 6 presents a dissolution pro?le of enteric-coated hard

berry extract has a pH of from about 2 to about 3.5. The

FIG. 7 shoWs a dissolution pro?le of enteric-coated hard

physically disrupted berries may be deWatered prior to being
exposed to the solvent composition, afterbeing exposed to the

capsules containing a berry extract according to the present

invention;
FIG. 8 shoWs inhibition of proliferation of HT-29 cells by

solvent composition, or both.

In another aspect, the present invention provides stabiliZed

a blackberry extract according to
FIG. 9 shoWs inhibition of IL-12 release from murine den

compositions having antioxidant and anti-in?ammatory
activity, prepared by the method of the invention as described
above. In one embodiment, a composition is provided having
antioxidant and anti-in?ammatory activity, comprising a

20

berry extract having at least one stable anthocyanin in an
amount effective to provide antioxidant and anti-in?amma

tory activity. The berry extract is provided by the steps of
physically disrupting a quantity of berries and exposing the
physically disrupted berries to a solvent composition having

illustrated in the accompanying draWings.
DETAILED DESCRIPTION OF THE INVENTION
25

Blackberries and raspberries, sometimes referred to as
“brambles”, are a species of fruit in the genus Rubus. Rubus is

a pH of from about 1 to about 3, Which stabiliZes the at least
one anthocyanin. The berry extract may be derived from a

quite diverse and has 12 subgenera With several of the sub

blackberry. Compositions comprising the berry extract of the

genera having more than a hundred species. In the United

present invention, formulated for oral and/ or topical admin

istration, are provided also, including Without gels, vanishing

30

Blackberries belong to the subgenus Eubatus, and have much
greater complexity than raspberries in terms of genetic back
ground, groWth characteristics, and number of species.

ods for treatment of in?ammation, oxidative stress, or cancer
35

40

and Arapaho. Other types of blackberries include, but are not
45

Thornless, Smoothstem, and Thomfree. In the Paci?c North
West, blackberries are often called Marionberries. Other ber

ries that have genetic similarity to blackberries include Boy
50

documents referenced in the present disclosure are incorpo

rated herein by reference in their entirety.
55

The accompanying draWings incorporated in and forming
60

C.;
FIG. 2 depicts a standard HPLC chromatogram of a black

function of pH and time;

as anthocyanins With as much as 1923 ug/ g Wet fruit. Sellap
pan et al. (2002) shoWed that blackberries had high concen

trations of ellagic acid; ChocktaW had 33.81 mg/100 g berry

poWder as a function of time When stored at 25° C. and at 40

FIGS. 3A and 3B shoW the stability of anthocyanins as a

acres. According to the USDA, of the blackberries harvested
in the US, about 40% are used for jams and jellies, 25% for
bakery products, 23% froZen or canned, and the 12% for
juices or other food.
Tsao et al. (2003) shoWed that, relative to other fruits,

blackberries have high concentrations of polyphenolics such

a part of the speci?cation, illustrate several aspects of the
present invention and together With the description serve to

berry extract made according to the present invention;

senberry, Loganberry, Olallieberry, and Youngberry. A 2002
report by the USDA lists the total US production of all black
berry types to be about 56 million pounds groWn on 8370

indicated, all patents, patent applications, and non-patent

explain the principles of the invention. In the draWings:
FIG. 1 shoWs percent Weight increase of active blackberry

Bailey, and BraZos. Semi-erect blackberries requiring a trellis

for production include Black Satin, Chester, Dirksen, Hull

ingly, the draWings and descriptions Will be regarded as illus

BRIEF DESCRIPTION OF THE DRAWINGS

erect including the thorny types, Cherokee, Comanche, Chey

limited to, Eldorado, Ebony King, Raven, Ranger, Hedrick,

invention is capable of other different embodiments and its
several details are capable of modi?cation in various, obvious
aspects all Without departing from the invention. Accord
trative in nature, and not as restrictive. Unless otherWise

Blackberries are native to Asia, Europe, North and South
America. They have been groWn in Europe for over 2000
years as food and for medical applications. Blackberries groW
in three different forms: trailing, semi-erect, and erect. In the
eastern half of the United States, the dominate form is the

enne, DarroW, Illini Hardy Blackberry, ShaWnee, and Choc
taW. The thornless cultivars include Hull, Chester, Navaho,

described herein are an illustration of one of the modes best

suited to carry out the invention. It Will be realiZed that the

States, R. allegheniensis, R. argulus, R. cuneifolius, R.
Canadensis, and R. Zrivialis are the dominant Rubus species.

lotions, vanishing creams, and the like.
In yet another aspect, the present invention provides meth
in a mammal in need thereof, comprising administering an
effective amount of the composition of the invention. Still yet
further, another aspect of the invention is compositions com
prising a therapeutically effective amount of the composition
of the invention, formulated in a pharmaceutically acceptable
vehicle. The composition may be provided in combination
With additional anticancer agents, additional anti-oxidant
agents, and/ or additional anti-in?ammatory agents.
As should be appreciated, the embodiments shoWn and

dritic cells by a blackberry extract according to the present
invention.
Reference Will noW be made in detail to the present pre
ferred embodiment of the invention, an example of Which is

65

and KioWa had 30.01 mg/100 g berry. Blackberries Were also
found to contain ?avonoids, With the major ?avonoid, cat
echin, present in ChoctaW at 312.86 mg/ 100 g berry. Sellap
pan shoWed that the average total anthocyanin and polyphe
nolic content in blackberries Was 116.591858 mg/100 g

berry and 486.53:97.13 mg/100 g berry, respectively.

US 7,964,223 B2
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stable, free -?oWing dry poWder. Optionally, a cryoprotectant

Accordingly, in one embodiment the present invention

describes methods for deriving stable compositions from
blackberries, and compositions made by those methods.
However, it Will easily be to many other types of fruits, plants,
and vegetables having an anthocyanin content, including but

may be added to material being freeZe-dried to reduce or

not limited to: straWberries, black raspberries, apple, cra

prevent chemical or physical damage to the material. Suitable
cryoprotectants include, but are not limited to, monosaccha
rides such as glucose, fructose, maltose, ribose, mannose, and
xylose, disaccharides such as trehalose, sucrose, myoinositol,

bapple, chokeberry, HaWthorn, Juneberry, Loquat, pear, apri

phosphorylated inositols, and glycerol, polysaccharides such

cot, cherry, plum, peach, various other raspberries, cloud

as hydroxyethyl starch, dextran, and hyaluronic acid, and

berry, Wineberry, salmonberry, bearberry, bilberry, cranberry,

polymers such as polyvinylpyrrolidone and chitosan.

huckleberry, barberry, currant, elderberry, gooseberry, hack

In another aspect, the present invention provides composi
tions having antioxidant and anti -in?ammatory activity, pre

berry, honeysuckle, nannyberry, sheepberry, sea grape, Wolf
berry, croWberry, goumi, kiWi, various other grapes, thimble

pared by the method of the invention as described above. In
one embodiment, a composition is provided having antioxi

berry, salmonberry, various types of melons such as

dant and anti-in?ammatory activity, comprising a berry

Watermelon, ?g, lime, avocado, feijoa, guava, kumquat, lon
gan, lychee, passion fruit, and pineapple.

extract having at least one stabiliZed anthocyanin in an
amount effective to provide antioxidant and anti-in?amma

In one aspect, the present invention provides a method for

preparing a composition having antioxidant and anti-in?am
matory activity, comprising exposing a berry to a solvent
composition having a pH of from about 1 to about 3, and
recovering a berry extract having a stabiliZed anthocyanin

tory activity. The berry extract may be provided by the steps
of physically disrupting a quantity of berries and exposing the
physically disrupted berries to a solvent composition Which
20

content. As discussed above, the berry may be a blackberry. In

one embodiment, the method comprises the steps of: physi

cally disrupting a quantity of berries, exposing the physically
disrupted berries to the solvent composition, and recovering a
berry extract having a pH of from about 1.0 to about 4.5. It

25

Will be appreciated that the ?nal pH of the extract Will depend
on both the concentration of the berry extract in the solvent

composition and on the speci?c solvent composition used for
extraction. The berry extract so recovered typically comprises
at least one stabiliZed anthocyanin in an amount effective to

30

provide antioxidant and anti-in?ammatory activity. In
another embodiment, the recovered berry extract has a pH of
about 3 .5. The stabiliZed anthocyanin may be a delphinidin, a
petunidin, a cyanidin, a pelargonidin, a peonidin, a malvidin,
or any combination thereof.

35

40

combinations thereof. Optionally, in place of the alcohol a
suitable ketone or a suitable halogenated ole?n may be used,
such as acetone, chloroform, methylene chloride, and mix

tures thereof. As discussed above, the physically disrupted

the alcohol (v/v). In yet another embodiment, the acid is
provided from about 0.01% to about 1% of the alcohol (v/v).
Any of a number of alcohols may be suitable for the present
invention, including, but not limited to, loWer chain alcohols

alcohol may be any suitable alcohol, including but not limited
to loWer chain alcohols such as methanol, ethanol, propanol,
butanol, and mixtures thereof. The acid may be any acid
suitable for providing the desired pH of the solvent compo

sition, including, but not limited to, hydrochloric acid, acetic
acid, citric acid, lactic acid, tri?uoroacetic acid, aspartic acid,
glutamic acid, formic acid, phosphoric acid, maleic acid, and

The physically disrupted berries may be exposed to a sol
vent composition comprising an alcohol and at least one acid,
With the acid provided in a suf?cient amount Whereby the
solvent composition has a pH of from about 1 to about 3. The
acid may be provided in an amount of from about 0.005% to
about 3% (v/v) of the alcohol. In one embodiment, the acid is
provided in an amount of from about 0.01% to about 2% of

stabiliZes the at least one anthocyanin. The berry extract may
be derived from a blackberry. In one embodiment, the berry
extract has a pH of from about 1.0 to about 4.5. In another
embodiment, the berry extract has a pH of about 3.5. The
stabiliZed anthocyanin may be a delphinidin, a petunidin, a
cyanidin, a pelargonidin, a peonidin, a malvidin, and combi
nations thereof.
The solvent composition may comprise an alcohol and at
least one acid, Wherein the acid is provided in an amount
suf?cient Wherein a pH of the solvent composition is from
about 1 to about 3. The acid may be provided in an amount of
from about 0.005% to about 3% (v/v) of the alcohol. The

berries may be deWatered to a Water content of up to 20%
45

(W/v), such as by freeZe-drying, either prior to exposing to the
solvent composition, after exposing to the solvent composi

such as methanol, ethanol, propanol, butanol, and mixtures

tion, or both. Still further, a cryoprotectant may be
A variety of formulations for oral and/ or topical adminis

thereof. The acid may be any acid suitable for providing the

tration are contemplated for the composition of the present

desired pH for the solvent composition, including, but not
limited, to hydrochloric acid, acetic acid, citric acid, lactic

invention. In one embodiment, a formulation for oral admin
50

istration is provided, comprising the berry extract in an
amount of from about 3% (W/W) to about 90% (W/W). In
another embodiment, a formulation for topical administration
is provided, comprising the berry extract in an amount of from

55

the skilled artisan that a large number of topical and oral

acid, tri?uoroacetic acid, aspartic acid, glutamic acid, sulfur
containing acids such as sulfonic acid, phosphoric acid,
maleic acid, and mixtures thereof. In yet another embodi

about 1% (W/W) to about 20% (W/W). It Will be appreciated by

ment, the alcohol can be replaced With a suitable ketone or a

suitable halogenated ole?n, such as acetone, chloroform,
methylene chloride, or mixtures thereof.

formulations are knoWn in the art, such as nutritional supple

The physically disrupted berries may be deWatered to a
residual Water content of up to 20% composition, or both. In

one embodiment, the physically disrupted berries are deWa
tered to a residual Water content of up to 10% (W/v). It Will be

60

appreciated that any suitable method may be employed for
deWatering, such as heating or centrifuging a berry puree to
remove Water, folloWed by crushing the dried berry puree to a

poWder. Typically, a poWder in accordance With the present

invention is prepared by lyophiliZation or freeZe-drying, i.e.,

65

ments, capsules, enteric-coated capsules, ?lm-coated cap
sules, tablets, enteric-coated tablets, ?lm-coated tablets,
cheWing gums, lotions, creams, mucoadhesive gels, vanish
ing lotions, vanishing creams, and the like. Other Ways to
apply a composition topically formulations are knoWn,
including but not limited to: sprays, ointments, gels, patches,
and needle-free devices that deliver their contents by diffu
sion, mechanical or gas-driven energy. The making of such
formulations and/or devices is Well Within the ability of the

freeZing folloWed by removal of Water by sublimation. Ben

skilled artisan, and such formulations and methods are con

e?cially, freeZe-drying provides a chemically and physically

templated also by the present invention.

US 7,964,223 B2
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For example, it is known to provide compositions in emul

ing typically targets the coated substance to the colon by
remaining undissociated or stable until a pH 7 environment is

sion or microemulsion form, as lotions and/or creams. A
lotion refers to a semi-viscous emulsion that is meant to be
applied to the skin. A cream refers to a more viscous emulsion
that is also meant to be applied to the skin. Lotions and creams
may be of the oil-in-Water or Water-in-oil type. In one

reached. Film -coating materials to achieve this goal include,
but are not limited to, EUDRAGIT-based polymers that are

soluble in intestinal ?uid at a pH greater than 7, pectin, amy

lose, and chitosan-based polymers.

embodiment of the present invention, lotions and creams of
the oil-in-Water type are provided Which stabilize a compo

It is also envisioned that a colon or tumor-speci?c ?lm

coating can be used on the oral dosage form that effectively

sition according to the present invention, and/or promote its
penetration into or through the skin layers.

serves to increase the delivered concentration of the compo

sition of the present invention by selective removal of the
coating by an endogenous enZyme present in the target tissue
of the small intestines, large intestines, colon, or rectum.

An emulsion refers to a biphasic opaque mixture of tWo
immiscible liquids stabiliZed by a surfactant. Emulsions are

thermodynamically unstable systems, and usually require the
application of high-torque mechanical mixing or homogeni

Alternatively, it is envisioned that tumors in the colon or

rectum can be targeted by coating the dosage form With a

Zation to produce dispersed droplets in the range of about 0.2

ligand speci?c for the tumor cell surface, i.e., Without limita

to 25 um. In contrast, a microemulsion is a stable biphasic

tion an antibody or binding fragment thereof.
A cheWing gum is a ?avored composition that is meant to
deliver a ?avor or other substance by cheWing. The primary
part of cheWing gum is the gum base, Which is a non-nutritive

mixture of tWo immiscible liquids stabiliZed by a surfactant
and usually a co-surfactant. Microemulsions are thermody

namically stable, isotropically clear, form spontaneously
Without excessive mixing, and have dispersed droplets in the

20

range of about 5 nm to 140 nm. Both microemulsions and
emulsions can be made as Water-in-oil or oil-in-Water sys

tems. In a Water-in-oil system, the dispersed phase is Water
and the continuous phase is oil. In an oil-in-Water system, the

dispersed phase is oil and the continuous phase is Water.

25

Whether Water-in-oil or oil-in-Water systems Will form is

largely in?uenced by the properties of the surfactant. The use
of surfactants that have hydrophilic-lipophilic balances
(HLB) of about 3-6 tend to promote the formation of Water
in-oil microemulsions While those With HLB values of about
8-18 tend to promote the formation of oil-in-Water micro
emulsions.
Formulations contemplated for oral administration
directly to the gastrointestinal tract include, but are not lim

30

ited to, nutritional supplements, capsules, enteric-coated cap

35

oxidants including butylated hydroxyanisole, butylated
With polysorbate 80, salts of carrageenan, furcelleran, salts of
45

50

for direct delivery to a mucosal surface and also for transmu

cosal delivery into systemic circulation. Brie?y, mucoadhe
55

the stomach, but ioniZe When the pH is above pH 4-5, pH 5-7,
60

sive polymer excipient refers to a polymer that has the ability
to adhere to mucin. Typically, for the compositions of the
present invention a mucoadhesive acidic polymer excipient is
used, Which When dissolved or suspended in Water results in
an acidic pH. In one embodiment, the mucoadhesive polymer
Will provide a polymer solution or suspension having a pH of
from about 1 to about 4.5. The polymer may be non-ionic or

anionic. Mucoadhesive polymer excipients Will typically be

polyvinyl acetate phthalate, hydroxypropylmethyl cellulose
phthalate, cellulose acetate trimellitate, carboxymethyl eth
ylcellulose, and hydroxypropyl methylcellulose acetate suc
including EUDRAGIT-based polymers. It is also contem
plated to provide ?lm-coated oral formulations. A ?lm-coat

for the gum, such as enjoyment (taste, mouth-feel, and the
like), breath freshening, dental care, and oral care.
Still further, the compositions of the present invention may

be provided along With a mucoadhesive polymer excipient,

tines, colon, or rectum. The most common enteric coatings
are those that remain intact (undissociated) in the loW pH of

cinate, and polymethacrylates (methacrylic acid copolymer)

furcelleran, gellan gum, and xanthan gum. Of course, com
positions in addition to those of the present invention may be
included as is knoWn in the art to provide desirable attributes

coated oral formulations. An enteric-coating refers to a coat
ing on an oral dosage form that is meant to cause the oral

or even above pH 7. Common enteric-coating materials
include, but are not limited to, cellulose acetate phthalate,

gum or Wood rosin, rice bran Wax, stearic acid, sodium and

hydroxytoluene, propyl gallate, carrageenan, carrageenan

The present invention contemplates providing enteric
dosage form to remain intact in the loWer pH of the stomach,
but disintegrate once the dosage form reaches the higher pH
of the intestines including the small intestines, large intes

thetic, polyethylene, polyisobutylene, and polyvinyl acetate,
plasticiZing materials including glycerol ester of partially
dimeriZed rosin, glycerol ester of partially hydrogenated gum

potassium stearates, synthetic and natural terpene resins, anti

and the like. In one embodiment, the formulation for oral
administration is a tablet or hard-gelatin capsule. In another
embodiment, the formulation is coated With a substance to
control the rate or location of disintegration, i.e., an enteric
coated or ?lm-coated formulation.

bases including chicle, chiquibul, croWn gum, gutta hang
kang, massaranduba balata, massaranduba chocolate, nis
pero, rosidinha, Venezuelan chicle, jelutong, leche capsi
(solva) perillo, leche de vaca, niger gutta, tunu, chilte, natural
rubber (smoked sheet and latex solids), synthetic substances
such as butadiene-styrene rubber, isobutylene-isoprene
copolymer, para?in, petroleum Wax, petroleum Wax syn

hydrogenated, pentaerythritol ester of partially hydrogenated
40

be prepared that is delivered to and retained in the mouth,
Whereby the contents and/ or the active ingredient primarily
drain into the stomach. Formulations meeting these criteria
include, but are not limited to, cheWing gums, gels, sprays,

loZenges, lollipops or other candies, rapidly dissolving strips,

voring agent, and an antioxidant. As an example, Subpart G
titled “Gum, CheWing Gum Bases and Related Substances”
may be used in gums, including arabinogalactan, natural gum

or Wood rosin, glycerol ester of polymeriZed rosin, glycerol
ester of gum rosin, glycerol ester of tall oil rosin, glycerol
ester of Wood rosin, lanolin, methyl ester of rosin partially

sules, ?lm-coated suspensions. It is envisioned that more
novel particle-based suspensions for oral administration can
be produced, such as emulsions, microemulsions, nanopar
ticle or microparticle suspensions. It is also contemplated in
this invention that a formulation for oral administration may

substance. The gum base may consist of any one or more of
the folloWing; an elastic ingredient, a resin that acts as a
binder and softener, a plasticiZer, ?llers, a sWeetener or ?a

selected Which also control the rate of release of the active

ingredient from the gel by providing a controlled rate of

polymer rehydration. The mucoadhesive polymer excipient
65

may be present in the dosage form in one embodiment in a

Weight percentage betWeen 5-50%. In another embodiment,
the excipient is present in a Weight percentage betWeen

US 7,964,223 B2
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AAPERAlcohol and Chemical Co. (Shelbyville, Ky.). HPLC
grade acetonitrile Was purchased from Fisher Scienti?c (Fair

5-20%. In yet another embodiment, the excipient is present in
a Weight percentage betWeen 5-10%. As non-limiting
examples, the mucoadhesive polymer excipient may be

LaWn, N.J.).

selected from one or more of the following polymers: poly

acrylic acid, crosslinked polyacrylic acid, polyvinyl pyrroli
done, cross-linked polyvinyl pyrrolidone, polymethacrylic
acid, polymethacrylic -acid co-polymers, carboxymethyl cel

EXAMPLE 1

A blackberry puree Was prepared by pulping Whole black

lulose, cellulose or derivatives thereof, or alginate.
Of course, additional substances may be included in the
formulations of the present invention to provide additional
desired properties, such as sWeeteners or preservatives.

berries. For purposes of this disclosure, the term pulping
refers to the process of removing the seeds and skin from
Whole fruit. HoWever, it Will be understood by those skilled in
the art that the skin and seeds also contain many biologically

SWeeteners glycerol, lactitol, maltitol, maltose, sorbitol, xyli

useful substances and so it is envisioned that the skin and
seeds may be retained for later use, or alternatively may be

tol, saccharin, aspartame, cyclamate, sucralose, or acesu
?ame potassium, or mixtures thereof. Preservatives are natu
ral or synthetic chemicals that are added to hinder spoilage,

kept With the fruit pulp rather than separated.
Blackberries Were picked from the vine and placed in con

Whether caused by microbial groWth, or unWanted chemical
changes such as, but not limited to, hydrolysis or oxidation.
Suitable preservatives may include, but are not limited to,

tainers for transporting to the picking station for inspection.
The berries Were not Washed in order to prevent deterioration

benZoic acid, sorbic acid, benZyl alcohol, benZethonium

chloride, butyl paraben, cetrimide, chlorobutanol, cresol,
ethyl paraben, phenol, phenoxyethanol, propylene glycol,
sodium benZoate, thimersol, methyl paraben, propyl paraben,

20

or mixtures thereof.

Still yet further, the present invention provides a method of
treating in?ammation, oxidative damage, or cancer, compris

25

blackberry puree free of skin and seeds. The blackberry puree
Was stored froZen at —200 C.

A VirTis Model AD2 LyophiliZer Was used to freeze-dry a

diverticulitis, ulcer, colitis, viral infection, bacterial infection,
35

blackberry puree, prepared as described in Example 1, to
produce a free-?oWing poWder. The cycle used a freeZer
temperature of —400 C., a condenser temperature of —500 C.,
and vacuum of 200 mTorr. Approximately 10 g of blackberry
puree in a glass lyophiliZation vial Was freeZe-dried. The
folloWing drying steps Were used to prepare a purple cake of

lFN-ot. The oxidative damage may be mediated at least par
tially by release of a free radical in the body of the mammal.

freeZe-dried blackberry puree:

The cancer may be a skin cancer, an oral cancer, a cancer of

the eye, a cancer of a mucosal surface such as the vagina, the

EXAMPLE 2

30

parasitic infection, and combinations thereof. The in?amma
tion may be partially mediated by the release in the body of
the mammal of at least one cytokine including, but not limited
to, an interleukin such as IL- 1, IL-6, or IL-12, or TNF-ot, and

blackberries Were passed through the Lagsenkamp Pulper at
a rate of 50-75 gallons/minute to produce a homogenous

ing administering to a mammal such as a human in need
thereof an effective amount of a composition as described
above. The in?ammation may be associated With cancer,

in?ammatory boWel disease, gastroesophageal re?ux dis
ease, diarrhea, radiation-induced enteritis, chemotherapy-in
duced enteritis, Crohn’s disease, irritable boWel syndrome,

of the Whole berry by surface Water. The seeds and skin of the
berries Were removed using a Langsenkamp type 161 Colos
sal Pulper having tWo agitator arms With brushes With a
stainless steel chamber, and stainless steel catch pan With tWo
outlets (one threaded and one With a sanitary ?tting) With a
10-horse poWer, 3 phase, 60 cycle, 230/460 volt meter. Whole

40

TABLE 1

nose, and the rectum, and combinations thereof. As described

above, the composition may be formulated for administration
by at least one of orally, topically, and by injection.
In yet still another aspect, the present invention provides
compositions for treating in?ammation, oxidative damage, or

Example Freeze-Drying Cycle for Blackberry Puree to
Produce Active Pharmaceutical Powder

in a pharmaceutically acceptable vehicle. The composition
may further comprise at least one additional anti-cancer
agent, at least one additional anti-oxidant, at least one addi

50

tional anti-in?ammatory agent, and combinations thereof.
The compositions may be formulated for administration by at
least one of orally, topically, and by injection as described
above.

The examples provided herein are presented in support of

55

and to further illustrate the invention as described above and
in the accompanying draWings, but are not to be considered as
limited thereto. Citations of literature herein are incorporated

into this disclosure by reference in their entirety unless oth

erWise indicated. Generally, 2,2'-AZinobis(3-ethylbenZothia
Zoline-6-sulfonic acid) diammonium salt (ABTS), Trolox

Temp

45

cancer in a mammal in need thereof, comprising a therapeu
tically effective amount of a composition as described above

Vacuum

Drying Steps

(0 C.)

Time (min)

(mTorr)

1
2
3
4

—35
—30
—25
—20

10
5
5
1200

200
200
200
200

5
6

—15
—10

840
10

200
200

7
8
9
10
11
12

—5
0
5
10
15
20

10
10
120
3 00
10
180

200
200
200
200
200
200

Post Heating

25

90

200

The freeZe-dried blackberry puree Was collected from the
60

glass lyophiliZation vial and milled using a mortar and pestle
to produce a free-?oWing reddish-purple poWder.

(6-hydroxy-2,5,7,8-tetramethychroman-2-carboxylic acid),
potassium persulfate, formic acid (ACS, >96%), 3-(4,5-dim
ethyl-thiaZol-2-yl)-2,5-diphenyl
tetraZolium
bromide
(MTT), Folin and Ciocalteau phenol reagent and gallic acid

(98% purchased from Flulca (St. Gallen, SWitZerland). USP
grade Ethanol (Absolutei200 proof) Was purchased from

EXAMPLE 3
65

A Hull lyophiliZer Was employed to create a second

embodiment of a dry poWder of the blackberry puree. A

partially froZen blackberry puree (Example 1) (5204 g) Was

US 7,964,223 B2
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placed into the lyophilizer on metal pans in large chunks. The
following lyophilization cycle shown in Table 2 Was used to

for 30 min With 60 mL of ethanol containing 0.01% HCl. The
supematants Were collected after ?ltration and dried by rotary

dry the blackberry puree:

evaporation at 40° C. The dried extract Was dissolved in 10
mL of deionized Water and ?ltered through a 1.0 pm nylon
syringe ?lter. The blackberry extract had a pH of 1.9. The
extract Was either frozen at —20° C., or lyophilized to produce
a dried blackberry extract (DBE) and then stored as a poWder
at —20° C. The average yield ofDBE Was 470.44:9.27 mg per

TABLE 2
Lyophilization Cycle Used to Produce
Freeze-Dried Blackberry Powder

Steps

gram of blackberry poWder.
The blackberry extract Was characterized for: i) mono

. Freeze to —40° C.

. Raise temp to —35° C.

meric anthocyanins and polymeric color measurement, ii)
Total Phenolic Measurement, iii) Trolox Equivalent Antioxi

. Once at —35° C., hold for 3 hr
. Set vacuum to less 150 microns

dant Capacity (TEAC) Assay, and iv) anthocyanin composi

. Raise temp to —10° C.

tion. Results of characterization for i, ii, and iii are shoWn in
Table 3 beloW. It is important to note that the values for these
several parameters are likely in?uenced by the extraction

. Once at —10° C., hold for 3 hr
. Maintain vacuum of less than 150 microns
. Raise temp to 0° C.

. Once at 0° C., hold for 3 hr

ef?ciency of the berry extract. Thus, it may be appreciated by

. Raise temp to 5° C.

. Once at 5° C., hold for 2.5 hr
. Raise temp to 10° C.

. Once at 10° C., hold for 2.4 hr
. Raise temp to 20° C.

20

those skilled in the art that a different extraction protocol may
result in a berry extract that has different composition and
features.

. Once at 20° C., hold for 2.5 hr

TABLE 3

. Break vacuum

Composition and Characterization of Dried Blackberg Extract DBE

The resulting blackberry poWder Weighed 559 g and Was
10.7% W/W of the initial blackberry puree that Was lyo

25

Total

Was treated under sonication With 500 mL ethanol containing
0.01% HCl for 30 min to produce a blackberry extract having
a pH in the range of 1.9-2.0. The suspension Was ?ltered and
the supernatant Was collected in a ?ask. The supernatant Was

Blackberry
extract

2.2 11.0

66.98 1 1.27

17.32 1 0.74

dTE: Trolox equivalent.
35

i) Monomeric Anthocyanins and Polymeric Color Mea
surement. Monomeric anthocyanin Were diluted 1:100 v/v in
a 25 mM potassium chloride buffer (pH 1.0) and a 0.4 M

Five hundred milligram portions of blackberry poWder

shoWn in FIG. 1, blackberry poWder stored at 25° C. increased
in Weight by up to 10% by 30 hr, and then reached a plateau.
In contrast, blackberry poWder stored at 40 C. increased in
Weight by less than 1 .7% and reached a plateau after only 5 hr.

(uM TEd/ g
DBE)

“Total anthocyanins Were expressed as cyanidin-3-glucoside equivalent.
bTotal phenolics Were expressed as gallic acid equivalent.
CTAC: total antioxidant capacity measured by Trolox-equivalent antioxidant capacity assay.

the original 100 g dried blackberry poWder.

prepared as described in Example 2 Were evaluated for rate of
Water sorption. Three vials Were held at 25° C. and three vials
Were held at 40 C. The percentage Weight increase over time
due to Water sorption Was recorded for a period of 45 hr. As

6.80 z 0.31

TACC

Polymeric
color (%)

30 (11 = 3)

dried at 400 C. for 7 hr using a rotary evaporator. The recov
ered blackberry extract Weighed 19.12 g or 19.12% W/W of

EXAMPLE 4

Total

Anthocyanins" Phenolicsl7
(mg/g DBE) (mgg DBE)

philized. Next, 100 g of the freeze-dried blackberry poWder

40

sodium acetate buffer (pH 4.5), then read against a blank at
510 nm and 700 nm With 1 cm path length disposable
cuvettes. Total anthocyanin content Was calculated using the

equations beloW.
A:(A510-A700) PH l-o-(Asro-Avoo) PH 4-5

Equation (1)

45

Where: A is the absorbance of the diluted anthocyanin

EXAMPLE 5

sample;
TWo different blackberry extracts Were obtained by sub

jecting 2.5 g blackberry poWder (Example 2) three times With
either; sample A) 20 mL of ethanol/0.1% HCl or, sample B)
20 mL of ethanol/0.01% HCl under sonication. The three
samples for each extraction condition Were red solution.
Ethanol Was then removed at 400 C. using a rotary evaporator
to obtain a dark red, viscous liquid. Ten (10) mL of Water Was
added to sample A to produce a dark-red suspension having a
pH of 1.2. Ten (10) mL of Water Was added to sample B to

50

coside);
DF is the dilution factor; and
e is the molar absorptivity (26900 for cyanidin-3-gluco

side).
55

by the ratio of polymerized color to color density.
ii) Total Phenolic Measurement. Total phenolic content in
60

EXAMPLE 6
65

pared as described in Example 2 Was treated under sonication

the berry extract Was estimated based on the method of

Singleton and Rossi (1965) using gallic acid as a standard.
TWenty (20) pL of diluted samples Was added to 1.58 mL
distilled Water along With 100 pL of a 2N Forlin-Ciocalteu
phenol reagent. All solutions Were mixed thoroughly and then

Will be discussed in greater detail beloW, the resulting com
positions are enriched for stabilized anthocyanins.

An aliquot of freeze-dried blackberry poWder (2.5 g) pre

Color density and polymeric color Were calculated using
absorption at 420, 510 and 700 nm With and Without bisul?te
treatment. The percentage of polymeric color Was determined

produce a dark-red suspension having a pH of 1.9. Both
sampleA and sample B Were centrifuged for 10 min at 12,000
g and a ?nal dark-red solution referred to berry extracts. As

C is the anthocyanin concentration (mg/ L);
MW is the molecular Weight (449.2 for cyanidin-3-glu

alloWed to sit at room temperature for 1 min. Three hundred

(300) pl saturated sodium carbonate solution (200 g/L) Was
then added to each sample. The absorbance Was measured at

